시장보고서
상품코드
1884614

HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 분석 및 예측(-2034년) : 유형별, 제품 유형별, 기술별, 용도별, 최종 사용자별, 컴포넌트별, 공정별, 기능별, 솔루션별, 투여 경로별

HIV Integrase Strand Transfer Inhibitors Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Component, Process, Functionality, Solutions, Mode

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 373 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

HIV 인테그라제 사슬 전이 억제제(INSTI) 시장은 2024년 59억 달러로 평가되었고 2034년까지 78억 달러에 이를 것으로 예측되며 CAGR은 약 3.5%를 나타낼 전망입니다. 이 시장은 바이러스 복제에 핵심적인 역할을 하는 HIV의 인테그라제 효소를 표적으로 하는 의약품으로 구성됩니다. 이러한 억제제는 HIV 치료의 핵심 단계인 바이러스 DNA의 숙주 게놈 내 통합을 방지합니다. 이 시장은 증가하는 HIV 유병률과 항레트로바이러스 치료법의 발전에 의해 주도되고 있습니다. 주요 트렌드로는 장기 작용 제형 및 복합 요법의 개발로 환자 순응도와 치료 결과가 향상되는 점이 포함됩니다. 혁신과 접근성에 초점을 맞춘 이 시장은 HIV 관리 분야의 미충족 의료 수요를 해결하며 상당한 성장을 이룰 준비가 되어 있습니다.

HIV 인테그라제 사슬 전이 억제제(INSTI) 시장은 항레트로바이러스 치료법의 발전과 증가하는 HIV 유병률에 힘입어 강력한 성장을 경험하고 있습니다. 약물 분류 부문은 여전히 우위를 점하고 있으며, 효능과 안전성 프로파일로 인해 돌루테그라비르 기반 치료법이 주도하고 있습니다. 복합 요법으로의 통합에 힘입어 비크테그라비르 기반 치료 옵션이 두 번째로 높은 성과를 보이는 하위 부문이 될 것으로 전망됩니다. 입원 환자 치료 및 기관 구매 증가로 인해 유통 채널 중 병원 약국 부문이 다른 부문을 앞지르고 있습니다. 소매 약국은 외래 처방 증가와 환자 편의성 향상으로 인해 그 뒤를 바짝 쫓고 있습니다. 제형 및 전달 방식의 혁신은 환자 순응도 향상과 부작용 감소에 대한 수요를 충족시키며 시장 역학을 더욱 촉진할 것으로 예상됩니다. 전략적 협력과 연구 투자는 시장 참여자들이 제품 포트폴리오를 확장하고 치료 성과를 향상시킬 수 있도록 하는 경쟁 우위의 핵심 촉진요인입니다. 맞춤형 의학과 표적 치료에 대한 집중은 향후 트렌드를 형성할 것으로 전망됩니다.

시장 세분화
유형 돌루테그라비르, 엘비테그라비르, 랄테그라비르, 비크테그라비르, 카보테그라비르
제품 정제, 캡슐, 주사제, 현탁액
기술 제제기술, 나노기술, 생명공학
용도 HIV-1 감염 치료, 노출 전 예방(PrEP), 노출 후 예방(PEP)
최종 사용자 병원, 진료소, 외래수술센터(ASC), 연구 기관
컴포넌트 유효성분(API), 첨가제
공정 화학 합성, 생물학적 합성
기능 항레트로바이러스 치료, 병용 요법, 단일 요법
솔루션 환자 관리, 의약품 개발, 규제 준수
투여 경로 경구 투여, 비경구 투여

HIV 인테그라제 사슬 전이 억제제(INSTI) 시장은 주요 제약사들의 다양한 제품 포트폴리오로 특징지어집니다. 시장 점유율은 전략적 가격 정책에 영향을 받으며, 신제품 출시로 인해 경쟁이 지속되고 있습니다. 이러한 신제품 출시는 소비자 관심 확보와 미충족 의료 수요 해결에 핵심적 역할을 합니다. 혁신적인 제형 및 전달 메커니즘은 환자 순응도와 치료 결과를 향상시켜 시장 환경을 더욱 변화시키고 있습니다. 주요 지역별 가격 전략은 현지 경제 상황과 의료 정책을 반영하여 다양하게 나타납니다. 이 시장의 경쟁은 치열하며, 주요 기업들은 연구 개발 투자를 통해 우위를 점하기 위해 노력하고 있습니다. 벤치마킹 결과, 탄탄한 파이프라인과 전략적 파트너십을 보유한 기업들이 시장에서 더 유리한 위치에 있는 것으로 나타났습니다. 규제 영향은 엄격한 지침 준수가 제품의 생존 가능성과 시장 진입을 보장하기 때문에 중요한 역할을 합니다. 규제 환경은 지역별로 달라 시장 역학과 성장 궤적에 영향을 미칩니다. 이러한 요소들을 이해하는 것은 새로운 기회를 활용하고 잠재적 도전을 헤쳐 나가려는 이해관계자들에게 매우 중요합니다.

세계적 관세와 지정학적 동향은 특히 동아시아에서 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장에 복잡한 영향을 미칩니다. 일본과 한국은 국내 제약 혁신을 강화하고 공급원을 다각화함으로써 무역 긴장을 헤쳐 나가고 있습니다. 중국은 수출 제한에 직면하여 의약품 원료 및 기술 자급자족을 위한 전략적 전환을 촉구하고 있습니다. 대만은 의약품 제조의 핵심 플레이어이지만, 미국과 중국 간의 지정학적 마찰에 취약한 상태를 유지하고 있습니다. 전 세계 HIV 치료 시장은 수요 증가와 혁신에 힘입어 견고한 성장세를 보이고 있으나, 공급망 차질로 인한 도전 과제에 직면해 있습니다. 2035년까지 시장 진화는 전략적 제휴와 탄력적인 공급망 구축에 달려 있을 것입니다. 중동 분쟁은 공급망 취약성을 악화시켜 제약 산업 전반의 에너지 가격과 운영 비용에 영향을 미치고 있습니다.

주요 동향과 촉진요인 :

HIV 인테그라제 사슬 전이 억제제(INSTI) 시장은 항레트로바이러스 치료법의 발전과 글로벌 인식 제고에 힘입어 성장하고 있습니다. 주요 동향으로는 환자 순응도를 높이고 투여 빈도를 줄이는 장기작용 제형 개발이 포함됩니다. 이러한 혁신은 HIV 감염자의 치료 성과와 삶의 질 향상에 핵심적입니다. 또한 신약 개발에 인공지능을 통합함으로써 새로운 억제제 개발이 가속화되어 유망한 치료 경로를 제시하고 있습니다. 시장 확대 촉진요인으로는 HIV 감염률 증가와 이에 따른 효과적인 치료 요법 수요가 있습니다. 정부 및 비영리 단체들은 HIV 유행 억제를 위해 연구 개발에 적극 투자하고 있습니다. 이러한 재정적 지원은 혁신과 접근성 증진에 핵심적입니다. 또한 맞춤형 의학으로의 전환은 효과 증대와 부작용 최소화를 위한 맞춤형 치료 전략에 대한 관심을 촉진하고 있습니다. 의료 인프라가 발전하고 첨단 치료 접근성이 확대되는 신흥 시장에는 풍부한 기회가 존재합니다. 경제성과 접근성을 최우선으로 하는 기업들은 상당한 시장 점유율을 확보할 유리한 위치에 있습니다. 또한 제약사와 연구 기관 간의 협력은 획기적인 치료법의 길을 열어 HIV 인테그라제 가닥 전이 억제제 시장의 지평을 넓히고 있습니다. 환자 치료 결과 개선과 미충족 의료 수요 해결에 대한 집중은 시장 성장을 지속적으로 주도하고 있습니다.

목차

제1장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 개요

  • 조사의 목적
  • HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 보고서 정의 및 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 기간 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 전망

  • HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTEL 분석
  • 밸류체인 분석
  • 4P 모델
  • 안조프 매트릭스

제5장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 규모

  • HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 규모(금액 기준)
  • HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 규모(수량 기준)

제7장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 유형별

  • 돌루테그라비르
  • 엘비테그라비르
  • 랄테그라비르
  • 비크테그라비르
  • 카보테그라비르
  • 기타

제8장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 제품별

  • 정제
  • 캡슐
  • 주사제
  • 현탁액
  • 기타

제9장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 기술별

  • 제제기술
  • 나노기술
  • 생명공학
  • 기타

제10장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 용도별

  • HIV-1 감염 치료
  • 노출 전 예방(PrEP)
  • 노출 후 예방(PEP)
  • 기타

제11장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 최종 사용자별

  • 병원
  • 진료소
  • 외래수술센터(ASC)
  • 연구기관
  • 기타

제12장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 컴포넌트별

  • 유효성분(API)
  • 첨가제
  • 기타

제13장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 공정별

  • 화학 합성
  • 생물학적 합성
  • 기타

제14장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 기능별

  • 항레트로바이러스 치료
  • 병용 요법
  • 단일 요법
  • 기타

제15장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 솔루션별

  • 환자 관리
  • 의약품 개발
  • 규제 준수
  • 기타

제16장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 투여 경로별

  • 경구
  • 비경구
  • 기타

제17장 HIV 인테그라제 사슬 전이 억제제(INSTI) 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제19장 기업 프로파일

  • ViiV Healthcare
  • Hetero Labs
  • Mylan Pharmaceuticals
  • Cipla
  • Aurobindo Pharma
  • Laurus Labs
  • Sun Pharmaceutical
  • Gilead Sciences
  • Dr Reddys Laboratories
  • Teva Pharmaceutical
  • Alkem Laboratories
  • Strides Pharma
  • Amneal Pharmaceuticals
  • Zydus Cadila
  • Glenmark Pharmaceuticals
  • Lupin Limited
  • Torrent Pharmaceuticals
  • Natco Pharma
  • Biocon
  • Jubilant Life Sciences
HBR

HIV Integrase Strand Transfer Inhibitors Market is anticipated to expand from $5.9 billion in 2024 to $7.8 billion by 2034, growing at a CAGR of approximately 3.5%. The HIV Integrase Strand Transfer Inhibitors Market comprises pharmaceuticals targeting HIV's integrase enzyme, crucial for viral replication. These inhibitors prevent viral DNA integration into the host genome, a pivotal step in HIV treatment. The market is driven by increasing HIV prevalence and advancements in antiretroviral therapy. Key trends include the development of long-acting formulations and combination therapies, enhancing patient adherence and outcomes. With a focus on innovation and accessibility, this market is poised for significant growth, addressing unmet medical needs in HIV management.

The HIV Integrase Strand Transfer Inhibitors Market is experiencing robust growth, fueled by advancements in antiretroviral therapy and increasing HIV prevalence. The drug class segment remains dominant, with Dolutegravir-based therapies leading due to their efficacy and safety profile. Bictegravir-based treatment options are projected to be the second highest performing sub-segment, driven by their integration into combination therapies. The hospital pharmacies segment outpaces others in the distribution channel, owing to the increasing number of inpatient treatments and institutional purchases. Retail pharmacies follow closely, benefiting from the rise in outpatient prescriptions and patient convenience. Innovations in drug formulations and delivery mechanisms are anticipated to further propel market dynamics, meeting the demand for improved patient compliance and reduced side effects. Strategic collaborations and research investments are key drivers of competitive advantage, enabling market players to expand their product portfolios and enhance therapeutic outcomes. The focus on personalized medicine and targeted therapies is expected to shape future trends.

Market Segmentation
TypeDolutegravir, Elvitegravir, Raltegravir, Bictegravir, Cabotegravir
ProductTablets, Capsules, Injectables, Suspensions
TechnologyPharmaceutical Formulation, Nanotechnology, Biotechnology
ApplicationTreatment of HIV-1 Infection, Pre-exposure Prophylaxis (PrEP), Post-exposure Prophylaxis (PEP)
End UserHospitals, Clinics, Ambulatory Surgical Centers, Research Institutes
ComponentActive Pharmaceutical Ingredients (API), Excipients
ProcessChemical Synthesis, Biological Synthesis
FunctionalityAntiretroviral Therapy, Combination Therapy, Monotherapy
SolutionsPatient Management, Drug Development, Regulatory Compliance
ModeOral, Parenteral

The HIV Integrase Strand Transfer Inhibitors market is characterized by a diverse array of product offerings from leading pharmaceutical companies. Market share is influenced by strategic pricing, which remains competitive due to the introduction of new product launches. These launches are pivotal in capturing consumer interest and addressing unmet medical needs. The market landscape is further shaped by innovative formulations and delivery mechanisms, which enhance patient adherence and therapeutic outcomes. Key regions are witnessing varied pricing strategies, reflecting local economic conditions and healthcare policies. Competition in this market is intense, with prominent firms striving for dominance through research and development investments. Benchmarking reveals that companies with robust pipelines and strategic partnerships are better positioned in the market. Regulatory influences play a critical role, as compliance with stringent guidelines ensures product viability and market entry. The regulatory landscape varies across regions, impacting market dynamics and growth trajectories. Understanding these elements is crucial for stakeholders aiming to capitalize on emerging opportunities and navigate potential challenges.

Geographical Overview:

The HIV Integrase Strand Transfer Inhibitors market is witnessing diverse growth across global regions. North America maintains a dominant position, fueled by advanced healthcare infrastructure and substantial research investments. The presence of key pharmaceutical companies further propels market expansion. Europe follows, with strong governmental support for HIV treatment and prevention initiatives, fostering a conducive environment for market growth. Asia Pacific emerges as a significant growth pocket, driven by increasing awareness and improved healthcare access. Countries like India and China are at the forefront, with rising investments in healthcare infrastructure and R&D. Latin America shows promising potential, with Brazil and Mexico leading the charge due to enhanced healthcare policies and growing awareness. In the Middle East & Africa, South Africa stands out as a key emerging country, driven by governmental efforts to combat HIV and improve healthcare access. This region is gradually recognizing the importance of innovative treatment solutions.

Global tariffs and geopolitical dynamics are intricately influencing the HIV Integrase Strand Transfer Inhibitors Market, particularly in East Asia. Japan and South Korea are navigating trade tensions by bolstering domestic pharmaceutical innovation and diversifying their supply sources. China is confronting export restrictions, prompting a strategic pivot towards self-sufficiency in pharmaceutical ingredients and technologies. Taiwan, while a key player in drug manufacturing, remains vulnerable to geopolitical frictions between the US and China. The global HIV treatment market is robust, driven by increasing demand and innovation, yet faces challenges from supply chain disruptions. By 2035, market evolution will be contingent upon strategic alliances and resilient supply networks. Middle Eastern conflicts exacerbate supply chain vulnerabilities, influencing energy prices and operational costs across the pharmaceutical sector.

Key Trends and Drivers:

The HIV Integrase Strand Transfer Inhibitors Market is experiencing growth driven by advancements in antiretroviral therapies and increasing global awareness. Key trends include the development of long-acting formulations that enhance patient adherence and reduce dosing frequency. These innovations are crucial in improving treatment outcomes and quality of life for individuals living with HIV. Furthermore, the integration of artificial intelligence in drug discovery is accelerating the development of novel inhibitors, offering promising therapeutic avenues. Drivers of market expansion include the rising prevalence of HIV infections and the subsequent demand for effective treatment regimens. Governments and non-profit organizations are actively investing in research and development to curb the HIV epidemic. This financial backing is crucial in fostering innovation and accessibility. Additionally, the shift towards personalized medicine is prompting a focus on tailored treatment strategies, enhancing efficacy and minimizing adverse effects. Opportunities are abundant in emerging markets where healthcare infrastructure is evolving, and access to advanced therapies is increasing. Companies that prioritize affordability and accessibility are well-positioned to capture significant market share. Furthermore, collaborations between pharmaceutical firms and research institutions are paving the way for breakthrough therapies, expanding the horizon for the HIV Integrase Strand Transfer Inhibitors Market. The focus on improving patient outcomes and addressing unmet medical needs continues to drive market growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: HIV Integrase Strand Transfer Inhibitors Market Overview

  • 1.1 Objectives of the Study
  • 1.2 HIV Integrase Strand Transfer Inhibitors Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Component
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Component
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: HIV Integrase Strand Transfer Inhibitors Market Outlook

  • 4.1 HIV Integrase Strand Transfer Inhibitors Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: HIV Integrase Strand Transfer Inhibitors Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: HIV Integrase Strand Transfer Inhibitors Market Size

  • 6.1 HIV Integrase Strand Transfer Inhibitors Market Size, by Value
  • 6.2 HIV Integrase Strand Transfer Inhibitors Market Size, by Volume

7: HIV Integrase Strand Transfer Inhibitors Market, by Type

  • 7.1 Market Overview
  • 7.2 Dolutegravir
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Elvitegravir
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Raltegravir
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Bictegravir
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Cabotegravir
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Others
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region

8: HIV Integrase Strand Transfer Inhibitors Market, by Product

  • 8.1 Market Overview
  • 8.2 Tablets
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Capsules
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Injectables
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Suspensions
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: HIV Integrase Strand Transfer Inhibitors Market, by Technology

  • 9.1 Market Overview
  • 9.2 Pharmaceutical Formulation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Nanotechnology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Biotechnology
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: HIV Integrase Strand Transfer Inhibitors Market, by Application

  • 10.1 Market Overview
  • 10.2 Treatment of HIV-1 Infection
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Pre-exposure Prophylaxis (PrEP)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Post-exposure Prophylaxis (PEP)
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: HIV Integrase Strand Transfer Inhibitors Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Ambulatory Surgical Centers
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Research Institutes
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: HIV Integrase Strand Transfer Inhibitors Market, by Component

  • 12.1 Market Overview
  • 12.2 Active Pharmaceutical Ingredients (API)
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Excipients
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: HIV Integrase Strand Transfer Inhibitors Market, by Process

  • 13.1 Market Overview
  • 13.2 Chemical Synthesis
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Biological Synthesis
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: HIV Integrase Strand Transfer Inhibitors Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Antiretroviral Therapy
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Combination Therapy
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Monotherapy
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: HIV Integrase Strand Transfer Inhibitors Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Patient Management
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Drug Development
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Compliance
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: HIV Integrase Strand Transfer Inhibitors Market, by Mode

  • 16.1 Market Overview
  • 16.2 Oral
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Parenteral
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: HIV Integrase Strand Transfer Inhibitors Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Component
    • 17.2.8 North America Market Size and Forecast, by Process
    • 17.2.9 North America Market Size and Forecast, by Functionality
    • 17.2.10 North America Market Size and Forecast, by Solutions
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Component
      • 17.2.9.7 United States Market Size and Forecast, by Process
      • 17.2.9.8 United States Market Size and Forecast, by Functionality
      • 17.2.9.9 United States Market Size and Forecast, by Solutions
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Component
      • 17.2.10.7 Canada Market Size and Forecast, by Process
      • 17.2.10.8 Canada Market Size and Forecast, by Functionality
      • 17.2.10.9 Canada Market Size and Forecast, by Solutions
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Component
    • 17.3.8 Europe Market Size and Forecast, by Process
    • 17.3.9 Europe Market Size and Forecast, by Functionality
    • 17.3.10 Europe Market Size and Forecast, by Solutions
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Component
      • 17.3.10.7 Germany Market Size and Forecast, by Process
      • 17.3.10.8 Germany Market Size and Forecast, by Functionality
      • 17.3.10.9 Germany Market Size and Forecast, by Solutions
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Component
      • 17.3.11.7 France Market Size and Forecast, by Process
      • 17.3.11.8 France Market Size and Forecast, by Functionality
      • 17.3.11.9 France Market Size and Forecast, by Solutions
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Component
      • 17.3.12.7 Spain Market Size and Forecast, by Process
      • 17.3.12.8 Spain Market Size and Forecast, by Functionality
      • 17.3.12.9 Spain Market Size and Forecast, by Solutions
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Component
      • 17.3.13.7 Italy Market Size and Forecast, by Process
      • 17.3.13.8 Italy Market Size and Forecast, by Functionality
      • 17.3.13.9 Italy Market Size and Forecast, by Solutions
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Component
      • 17.3.14.7 Netherlands Market Size and Forecast, by Process
      • 17.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Component
      • 17.3.15.7 Sweden Market Size and Forecast, by Process
      • 17.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Component
      • 17.3.16.7 Switzerland Market Size and Forecast, by Process
      • 17.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Component
      • 17.3.17.7 Denmark Market Size and Forecast, by Process
      • 17.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Component
      • 17.3.18.7 Finland Market Size and Forecast, by Process
      • 17.3.18.8 Finland Market Size and Forecast, by Functionality
      • 17.3.18.9 Finland Market Size and Forecast, by Solutions
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Component
      • 17.3.19.7 Russia Market Size and Forecast, by Process
      • 17.3.19.8 Russia Market Size and Forecast, by Functionality
      • 17.3.19.9 Russia Market Size and Forecast, by Solutions
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Component
      • 17.4.9.7 China Market Size and Forecast, by Process
      • 17.4.9.8 China Market Size and Forecast, by Functionality
      • 17.4.9.9 China Market Size and Forecast, by Solutions
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Component
      • 17.4.10.7 India Market Size and Forecast, by Process
      • 17.4.10.8 India Market Size and Forecast, by Functionality
      • 17.4.10.9 India Market Size and Forecast, by Solutions
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Component
      • 17.4.11.7 Japan Market Size and Forecast, by Process
      • 17.4.11.8 Japan Market Size and Forecast, by Functionality
      • 17.4.11.9 Japan Market Size and Forecast, by Solutions
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Component
      • 17.4.12.7 South Korea Market Size and Forecast, by Process
      • 17.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Component
      • 17.4.13.7 Australia Market Size and Forecast, by Process
      • 17.4.13.8 Australia Market Size and Forecast, by Functionality
      • 17.4.13.9 Australia Market Size and Forecast, by Solutions
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Component
      • 17.4.14.7 Singapore Market Size and Forecast, by Process
      • 17.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Component
      • 17.4.15.7 Indonesia Market Size and Forecast, by Process
      • 17.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Component
      • 17.4.16.7 Taiwan Market Size and Forecast, by Process
      • 17.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Component
      • 17.4.17.7 Malaysia Market Size and Forecast, by Process
      • 17.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Component
    • 17.5.8 Latin America Market Size and Forecast, by Process
    • 17.5.9 Latin America Market Size and Forecast, by Functionality
    • 17.5.10 Latin America Market Size and Forecast, by Solutions
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Component
      • 17.5.9.7 Brazil Market Size and Forecast, by Process
      • 17.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Component
      • 17.5.10.7 Mexico Market Size and Forecast, by Process
      • 17.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Component
      • 17.5.11.7 Argentina Market Size and Forecast, by Process
      • 17.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Component
      • 17.6.10.7 UAE Market Size and Forecast, by Process
      • 17.6.10.8 UAE Market Size and Forecast, by Functionality
      • 17.6.10.9 UAE Market Size and Forecast, by Solutions
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Component
      • 17.6.11.7 South Africa Market Size and Forecast, by Process
      • 17.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 ViiV Healthcare
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Hetero Labs
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Mylan Pharmaceuticals
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Cipla
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Aurobindo Pharma
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Laurus Labs
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sun Pharmaceutical
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Gilead Sciences
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Dr Reddys Laboratories
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Teva Pharmaceutical
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Alkem Laboratories
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Strides Pharma
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Amneal Pharmaceuticals
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Zydus Cadila
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Glenmark Pharmaceuticals
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Lupin Limited
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Torrent Pharmaceuticals
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Natco Pharma
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Biocon
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Jubilant Life Sciences
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제